Posts Tagged: march-in rights


A Pandemic Can’t Stop Bayh-Dole—But Politicians Might

What would you say about a technology commercialization system that kept on performing even through the worst pandemic in over a century? How about if it improved …
By Joseph Allen
3 months ago 1

Don’t Go Down the Rabbit Hole with the Foes of Bayh-Dole

Sensing an opening after the Biden Administration’s recent Executive Order put a hold on a pending regulation prohibiting the misuse of the march-in rights provision of …
By Joseph Allen
4 months ago 1

BIO Urges NIST to Continue Successful Public-Private Partnership in Recent Comments

The Biotechnology Innovation Organization (BIO) recently submitted comments in support of a National Institute of Standards and Technology [NIST] rulemaking on “Rights to Federally Funded Inventions and …
By Melissa Brand
7 months ago 0

Industry Comments on Proposed Changes to Bayh-Dole Regulations Zero in on March-In Language

On January 12, the National Institute of Standards and Technology (NIST) published a request for comments on proposed changes to regulations that support the University and Small Business …
By Gene Quinn
8 months ago 0

Commenters on Bayh-Dole Rule Object to Mention of ‘Pricing’ in March-In Provision

Two organizations with which I work have filed comments with NIST on its Bayh-Dole regulatory proposals. The National Institute of Standards and Technology, or NIST, approaches completion …
By James Edwards
8 months ago 2

The Biden Administration is at an Innovation Crossroad

The new Presidential Administration has hardly settled in before being confronted with a stark choice: will they continue policies that foster public/private sector R&D partnerships …
By Joseph Allen
10 months ago 2

A Swing (and a Miss) at NIH Tech Transfer

How many people or organizations could undergo an exhaustive investigation into everything they've done over the past 30 years and emerge unscathed? That's what just happened to the …
By Joseph Allen
1 year ago 0

Property Rights and State AGs’ Assault on Remdesivir: A Conservative Perspective

By now, everyone in the IP arena has heard about the demands of more than 30 state and territorial attorneys general (AGs) regarding the promising COVID treatment remdesivir. …
By James Edwards
1 year ago 11

No, You Can’t March in On Remdesivir

One thing you should never say in 2020 is: "Well, at least things can't get any worse." They can and often do. The latest exhibit—in the intellectual …
By Joseph Allen
1 year ago 5

Don’t Let Life Sciences Innovation Become Another Coronavirus Casualty

With two-thirds of the world in lockdown and no clear way out of the novel coronavirus crisis, it’s increasingly obvious that biopharmaceutical innovation will play a …

Will Bayh-Dole Survive Its 40th Birthday?

Next year marks the 40th anniversary of the passage of the Bayh-Dole Act. With election day looming, 2020 is likely to be the most politically contentious year of …
By Joseph Allen
2 years ago 1

Bayh-Dole Rocks While the Critics Play the Same False Note

A just-released study co-sponsored by the Biotechnology Innovation Organization (BIO) and AUTM provides new evidence of the significant contribution academic patent licensing makes to the U.S. …
By Joseph Allen
2 years ago 0

Knowledge Ecology International Letter Misleads on March-In Rights

Recently, Knowledge Ecology International sent to Congress a letter objecting to the draft “Green Paper on Unleashing American Innovation” disseminated by the National Institute of Standards and …
By Frederick-Reinhart
3 years ago 10

The Washington Post Misses the Mark on March-In Rights

The National Institute of Standards and Technology recently indicated in its "Return on Investment Initiative draft green paper" that it would issue regulations effectively ending attempts to …
By Joseph Allen
3 years ago 2

Special Interests are Watching Academic Tech Transfer

The original motivation for the Bayh-Dole Act was to encourage the commercialization of academic innovation so that new technologies could be available for the benefit of all. …
By Nikki Borman
3 years ago 0